SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) Public Ltd Co - Ordinary Shares - Class A

SMX is trending due to a significant price surge, with community members discussing short squeezes and potential for further gains. The stock's low float and high short interest are fueling speculation and volatility, while some traders express caution due to the company's history of reverse splits. Recent news related to Dubai's DMCC may also be contributing to the increased attention.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

$IMG is trending as community members highlight the token's passive $SOL rewards system, which distributes Solana to holders based on volume, regardless of price movement; this is often referred to as the 'infinite money glitch'. Community members emphasize its long-term building, transparent mechanics, and potential for real-world utility, particularly within the GTA economy, contributing to current bullish sentiment.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Amidst Bitcoin's recent volatility, Marathon Digital is trending as community members debate its underperformance compared to other miners and its management's strategy. Concerns around executive compensation and potential dilution are contrasted with the company's Bitcoin holdings and assets. Some traders express optimism for a potential short squeeze, while others voice frustration, calling for leadership changes.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss Tether's recent investment and broader commitments to Rumble's advertising and cloud services. The community anticipates a potential short squeeze, fueled by high short interest and Tether's increased stake in the company, with some speculating on a year-end rally. Discussions also involve Rumble's potential in the cloud computing space and its relationship with crypto.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma is trending, fueled by community discussion around the company's lawsuit alleging stock market manipulation and anticipation of upcoming news, potentially a settlement. The community is very bullish, with some highlighting the potential for a squeeze, while others point to the broader context of the company's MS drug development program as a catalyst.

mashene boken, can i get u anyting els? 🍟

McBROKEN

McBROKEN is trending as community members discuss its potential for a breakout, pointing to accumulation patterns and consistent buying activity. Some investors highlight the token's resilience and controlled price action despite market pullbacks. The conversation also includes speculation about staking and the token's overall technical structure.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems $OSS is trending due to a surge in volume and positive sentiment, with community members speculating about potential news or contracts, particularly related to military applications and AI. Discussions highlight the company's strong fundamentals, low market cap relative to revenue, and partnership with NVIDIA. The community is closely watching for a breakout, with some members setting ambitious long-term price targets.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions about its relationship with crypto, particularly following news of institutional clients being able to use Bitcoin as collateral and the launch of JPM Coin on Coinbase's Base chain; these moves spark debate, given CEO Jamie Dimon's past criticism of crypto. Some traders are also discussing JPM's potential involvement with other companies and its overall impact on the broader market.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as community members spread awareness of the self-proclaimed "infection" and "pressure" surrounding the meme coin, which originated from $PUMP on the Solana blockchain. Community members highlight the coin's fun, active community and potential for significant growth, emphasizing that early participation is key to capitalize on the $PMV movement. The coin is also gaining traction for its association with meme culture and the broader $SOL ecosystem.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending amid discussions about AI's potential impact on biotech and pharmaceutical industries, with some investors highlighting the sector's biggest rally since 2004. Community members are actively debating the sustainability of the biotech surge, particularly concerning layoffs, closures, and mergers, while others point to AI-driven advancements in drug discovery and personalized medicine. Some traders are noting the technicals indicate the run is overextended and will have an epic pull back, while some are loading the inverse ETF, LABD.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arbutus Biopharma (NASDAQ:ABUS) Given Buy Rating at Chardan Capital

Chardan Capital reiterated a "buy" rating and issued a $5.00 price target on shares of Arbutus Biopharma in a research report on Friday...

Arbutus Biopharma (NASDAQ:ABUS) Downgraded by Wall Street Zen to Hold

Wall Street Zen cut Arbutus Biopharma from a "buy" rating to a "hold" rating in a research report on Saturday...

Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.04) EPS for the quarter, topping analysts' consensus...

Are Medical Stocks Lagging  Arbutus Biopharma (ABUS) This Year?

Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?

Here is how Novartis (NVS) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?

Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

Here is how Aquestive Therapeutics (AQST) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

ABUS
Arbutus Biopharma Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABUS News

ABUSArbutus Biopharma Corp